slides · global inventory
Sequoia Pitch
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 43,093
Current window 24,121-24,150
Pages 1,437
Rows per page 30
Arc
24,121-24,150 of 43,093
07
Includes footnotes defining active partners and active programs.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
08
OmniAb | Investor Presentation Deck | 35 slidesOmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
09
The chart shows a steady increase in clinical programs from 2016 to mid-2023.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
10
The slide uses a column-based layout to track progress for specific drug programs (Batoclimab, IMVT-1402, CSX-1004, APVO436, GSK Program-1).OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
11
The slide uses a linear process flow to describe the core value proposition.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The slide uses a process-oriented framework to categorize various proprietary technologies.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
13
OmniAb | Investor Presentation Deck | 35 slidesOmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
14
The slide uses a process-oriented header (Create, Screen, Deliver) and lists specific proprietary technologies (OmniRat, OmniMouse, etc.) alongside value propositions.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
The slide illustrates the genetic mechanism of the platform, showing how human V, D, and J genes are combined with rat constant regions to facilitate robust immune responses, followed by conversion to fully human antibodies.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
Uses a phylogenetic-style timeline to show the split between avian and mammalian lineages.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
Includes a scientific citation (Stanfield et al. Sci Adv 2020) and mentions 'Picobodies' as a specific product/format.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
The slide uses a process diagram to show the convergence of two platforms into a single bispecific product format.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
19
The slide uses a hybrid layout combining a gallery of antibody structural diagrams with a pie chart representing market/clinical distribution.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
20
The slide uses a table format to differentiate proprietary platforms (OmniMouse, OmniRat, OmniChicken, OmniFlic, OmniClic, OmniTaur).OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
21
The slide uses a process diagram to contrast two distinct R&D workflows.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
22
The slide highlights the third stage of a three-part process (Create, Screen, Deliver).OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
28
The table displays revenue, operating expenses, and net loss figures in millions, along with per-share data.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
29
The slide includes a summary of financial health and cash runway expectations.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
30
The table displays financial performance in millions of dollars, highlighting a mix of revenue streams and operating costs.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
31
The table provides a year-over-year variance analysis for key financial line items.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
32
The slide provides a quantitative summary of the capital structure as of June 30, 2023.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
06
The slide uses a maturity model framework to define the evolution of pharmacy operations.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Pitch deck Investor relations Beat · Problem1 hit
09
Omnicell | Investor Presentation Deck | 27 slidesOmnicell | Investor Presentation Deck | 27 slides · Omnicell
Pitch deck Investor relations Beat · Market Size1 hit
10
The slide highlights the shift toward recurring revenue models.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Pitch deck Investor relations Beat · Business Model1 hit
11
The slide uses a visual comparison of bar charts to illustrate the shift from upfront product revenue to recurring revenue models.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Pitch deck Investor relations Beat · Business Model1 hit
12
The slide uses a grouped bar chart to show financial health over time.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Pitch deck Investor relations Beat · Financials1 hit
13
The slide provides a detailed financial reconciliation of backlog, distinguishing between product and services, and short-term vs long-term components.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Pitch deck Investor relations Beat · Financials1 hit
14
Includes footnotes detailing specific service and product inclusions.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Pitch deck Investor relations Beat · Financials1 hit
15
Includes a disclaimer regarding Non-GAAP financial measures.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Pitch deck Investor relations Beat · Financials1 hit
16
Includes detailed footnotes defining bookings and TAM scope.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Pitch deck Investor relations Beat · Financials1 hit